New Product Alert: Weight Loss Telemedicine Program
|
Time to read 2 min
|
Time to read 2 min
We are excited to announce that we are launching our Weight Loss Telemedicine Program to offer GLP-1 medications like Ozempic, Mounjaro, compounded semaglutide, and compounded tirzepatide. This means you can now easily obtain GLP-1 medications from the comfort of your home.
We have partnered with CareGLP to combine their medical expertise and advanced telemedicine infrastructure with our commitment to exceptional customer experience. Our program boasts:
GLP-1 medications are new treatments for type 2 diabetes and obesity. They work by mimicking a natural hormone to help people keep their blood sugar levels steady and lose weight.
In addition to managing weight loss, emerging research suggests GLP-1s can also play a role in mitigating sleep apnea symptoms. Recent studies found that Ozempic can positively impact sleep apnea symptoms, demonstrating:
Due to high demand, the current backlog for telemedicine consultations is up to 10 business days. We understand that this delay can be frustrating for anyone who is ready to start GLP-1 immediately, and we wish the turnaround were faster. However, our best advice is to book your consultation as soon as possible. Given the explosive growth in demand for GLP-1, it’s more likely that wait times will increase than decrease in the near future. Secure your spot now to start your weight loss journey sooner!
If you have any suggestions, concerns, or inquiries regarding the Weight Loss Telemedicine Program or the ordering process, please reach out to us directly at GLP@easybreathe.com.
Eli Lilly, the manufacturer of Zepbound, released preliminary findings on the effect of their drug on sleep apnea patients. Lilly’s study focused on two groups of international males, each participant receiving injections of Zepbound at doses ranging from 10 to 15 mg over a year. The results showed:
By coupling the metabolic benefits of GLP-1s with the respiratory support of CPAP therapy, sleep apnea treatment may become more effective than ever before. 3